Prasanna Weerawansa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Prasanna Weerawansa has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Hemal Senanayake
Rajarata University of Sri Lanka
8 shared publications - Sisira Siribaddana
Department of Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka
6 shared publications - Anjana Silva
Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka
2 shared publications - Chamara Sarathchandra
Department of Medicine Faculty of Medicine and Allied Sciences Rajarata University of Sri Lanka
2 shared publications - Koralegedara Dayaratne
Teaching Hospital Anuradhapura Sri Lanka
2 shared publications - Kosala Weerakoon
Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura 50008, Sri Lanka
2 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (2) , 5-7
Navigating the “Perfect Storm”: Clinical Challenges of Managing Leptospirosis in Resource-Limited Settings
- 2 September 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (2) , 5-7
Open AccessNavigating the “Perfect Storm”: Clinical Challenges of Managing Leptospirosis in Resource-Limited Settings
- Open Access
- 26 May 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (1) , 9-23
A Multicenter Double-blind Randomised Parallel Group Phase Three Superiority Clinical Trial on the Effectiveness of Dextran 40 Compared to Normal Saline in Preventing Dengue Shock in the Early Leakage Phase of Dengue Haemorrhagic Fever: Study Protocol
Background: Dengue haemorrhagic fever (DHF) remains a major cause of morbidity in tropical countries, with progression to shock contributing substantially to mortality. Early plasma leakage with organ hypoperfusion may represent a critical therapeutic window for intervention. This study evaluates whether dextran-40 is superior to normal saline in preventing dengue shock during the early leakage phase of DHF.Methods: The Dextran in the Early Leakage Phase of Dengue Prevents Shock (DELPODS) study is a multicenter, double-blind, randomised, parallel-group phase III superiority trial conducted in Sri Lanka. Adults aged ≥18 years with confirmed dengue fever and evidence of early plasma leakage with organ hypoperfusion are randomised to receive either intravenous dextran-40 (5 mL/kg; maximum 250 mL) or 0.9% normal saline at an equivalent dose infused over 2 hours. Patients with advanced plasma leakage, established shock, pregnancy, acute kidney injury, advanced chronic kidney disease, severe heart failure, severe liver disease, or dextran hypersensitivity are excluded. The planned sample size is 218 participants.Outcomes: The primary outcome is the incidence of shock within 48 hours of randomisation. Secondary outcomes include maintenance of haemodynamic stability, time to haemodynamic instability, need for additional fluid therapy, clinical outcomes at discharge, and safety outcomes including fluid overload, acute kidney injury, and hypersensitivity reactions.Ethics and Registration: Ethical approval was obtained from the Ethics Review Committee of the Faculty of Medical & Allied Sciences, Rajarata University of Sri Lanka (22 June 2022). The trial is registered with the Sri Lanka Clinical Trial Registry (SLCTR/2022/003; U1111-1272-4389).
- 26 May 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (1) , 9-23
Open AccessA Multicenter Double-blind Randomised Parallel Group Phase Three Superiority Clinical Trial on the Effectiveness of Dextran 40 Compared to Normal Saline in Preventing Dengue Shock in the Early Leakage Phase of Dengue Haemorrhagic Fever: Study Protocol
Background: Dengue haemorrhagic fever (DHF) remains a major cause of morbidity in tropical countries, with progression to shock contributing substantially to mortality. Early plasma leakage with organ hypoperfusion may represent a critical therapeutic window for intervention. This study evaluates whether dextran-40 is superior to normal saline in preventing dengue shock during the early leakage phase of DHF.Methods: The Dextran in the Early Leakage Phase of Dengue Prevents Shock (DELPODS) study is a multicenter, double-blind, randomised, parallel-group phase III superiority trial conducted in Sri Lanka. Adults aged ≥18 years with confirmed dengue fever and evidence of early plasma leakage with organ hypoperfusion are randomised to receive either intravenous dextran-40 (5 mL/kg; maximum 250 mL) or 0.9% normal saline at an equivalent dose infused over 2 hours. Patients with advanced plasma leakage, established shock, pregnancy, acute kidney injury, advanced chronic kidney disease, severe heart failure, severe liver disease, or dextran hypersensitivity are excluded. The planned sample size is 218 participants.Outcomes: The primary outcome is the incidence of shock within 48 hours of randomisation. Secondary outcomes include maintenance of haemodynamic stability, time to haemodynamic instability, need for additional fluid therapy, clinical outcomes at discharge, and safety outcomes including fluid overload, acute kidney injury, and hypersensitivity reactions.Ethics and Registration: Ethical approval was obtained from the Ethics Review Committee of the Faculty of Medical & Allied Sciences, Rajarata University of Sri Lanka (22 June 2022). The trial is registered with the Sri Lanka Clinical Trial Registry (SLCTR/2022/003; U1111-1272-4389).
- Open Access
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4)
Self-injection of kerosene with chemical pneumonitis and abscess formation ‒ a case report and literature review
Introduction and aim. Kerosene, a widely available household fuel in Sri Lanka, is a common cause of accidental poisoning, especially in children, and is occasionally used for self-harm, which can cause complications such as chemical pneumonitis, abscesses, and thrombosis. Its unsafe storage practices increase the risk of accidental exposure. Description of the case. A 16-year-old Sri Lankan male self-injected kerosene into the left cubital fossa. Although initially stable, he later developed chemical pneumonitis, left cephalic vein thrombosis, and a sterile abscess at the injection site. Conclusion. Early multidisciplinary intervention and close clinical monitoring led to a favorable outcome. A review of the literature reveals that intravenous hydrocarbon injection, although rare, can lead to significant local and systemic toxicities.
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4)
Open AccessSelf-injection of kerosene with chemical pneumonitis and abscess formation ‒ a case report and literature review
Introduction and aim. Kerosene, a widely available household fuel in Sri Lanka, is a common cause of accidental poisoning, especially in children, and is occasionally used for self-harm, which can cause complications such as chemical pneumonitis, abscesses, and thrombosis. Its unsafe storage practices increase the risk of accidental exposure. Description of the case. A 16-year-old Sri Lankan male self-injected kerosene into the left cubital fossa. Although initially stable, he later developed chemical pneumonitis, left cephalic vein thrombosis, and a sterile abscess at the injection site. Conclusion. Early multidisciplinary intervention and close clinical monitoring led to a favorable outcome. A review of the literature reveals that intravenous hydrocarbon injection, although rare, can lead to significant local and systemic toxicities.
- 18 April 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (9) , 1055-1058
Haemoconcentration in diagnosing dengue haemorrhagic fever: evidence from a rural Sri Lankan observational study
Background: One of the World Health Organization criteria for dengue haemorrhagic fever (DHF) is a 20% increase in haematocrit. This study on dengue hospitalised patients compares haematocrit levels at baseline, at the onset of the critical phase and the maximum during the critical phase in rural Sri Lanka. Methods: This observational study included patients with dengue in the febrile phase who progressed to the critical phase. Haematocrit was recorded and ultrasound scans were performed thrice daily when the platelet count dropped to <100 000/μl. The onset of the critical phase was confirmed by ultrasound-detected plasma leakage. Results: Forty-three patients were included in the final analysis. The mean haematocrit at baseline and at the onset of the critical phase was 40.6% (standard deviation [SD] 4.7) and 41.3% (SD 5.1), respectively, with no difference (p=0.14, paired t-test). None of the participants showed a 20% increase in haematocrit at the onset of the critical phase, with the maximum observed increase being 17.0%. Conclusion: A 20% increase in haematocrit was not observed during the critical phase, suggesting that haemoconcentration is unreliable for diagnosing DHF in hospitalised patients. This study recommends revisiting the WHO criterion of a 20% haematocrit increase for diagnosing plasma leakage in dengue patients. It suggests that frequent ultrasound scans may be a more reliable method for early detection of plasma leakage.
- 18 April 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (9) , 1055-1058
Haemoconcentration in diagnosing dengue haemorrhagic fever: evidence from a rural Sri Lankan observational study
Background: One of the World Health Organization criteria for dengue haemorrhagic fever (DHF) is a 20% increase in haematocrit. This study on dengue hospitalised patients compares haematocrit levels at baseline, at the onset of the critical phase and the maximum during the critical phase in rural Sri Lanka. Methods: This observational study included patients with dengue in the febrile phase who progressed to the critical phase. Haematocrit was recorded and ultrasound scans were performed thrice daily when the platelet count dropped to <100 000/μl. The onset of the critical phase was confirmed by ultrasound-detected plasma leakage. Results: Forty-three patients were included in the final analysis. The mean haematocrit at baseline and at the onset of the critical phase was 40.6% (standard deviation [SD] 4.7) and 41.3% (SD 5.1), respectively, with no difference (p=0.14, paired t-test). None of the participants showed a 20% increase in haematocrit at the onset of the critical phase, with the maximum observed increase being 17.0%. Conclusion: A 20% increase in haematocrit was not observed during the critical phase, suggesting that haemoconcentration is unreliable for diagnosing DHF in hospitalised patients. This study recommends revisiting the WHO criterion of a 20% haematocrit increase for diagnosing plasma leakage in dengue patients. It suggests that frequent ultrasound scans may be a more reliable method for early detection of plasma leakage.
- Open Access
- 1 May 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (1) , 29-32
A young patient with cord compression diagnosed as a solitary sacral plasmacytoma: a case report
Plasmacytoma is a subgroup of plasma cell neoplasms characterized by localized proliferation of neoplastic plasma cells. It is a rare disease that accounts for only less than 5% of all plasma cell tumours and can present alone or with multiple myeloma. Here, we report a clinical case of unusual presentation, in which solitary sacral plasmacytoma of a previously well young woman presented with bilateral lower limb numbness. She was found to have a sacral-originated tumour, which was later diagnosed as a solitary sacral plasmacytoma with the help of imaging and histological evaluation, along with the absence of the end organ damage.
- 1 May 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (1) , 29-32
Open AccessA young patient with cord compression diagnosed as a solitary sacral plasmacytoma: a case report
Plasmacytoma is a subgroup of plasma cell neoplasms characterized by localized proliferation of neoplastic plasma cells. It is a rare disease that accounts for only less than 5% of all plasma cell tumours and can present alone or with multiple myeloma. Here, we report a clinical case of unusual presentation, in which solitary sacral plasmacytoma of a previously well young woman presented with bilateral lower limb numbness. She was found to have a sacral-originated tumour, which was later diagnosed as a solitary sacral plasmacytoma with the help of imaging and histological evaluation, along with the absence of the end organ damage.
- Open Access
- 30 April 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (1) , 23-28
Mantle cell lymphoma in HIV infection: First reported case in Sri Lanka
Non Hodgkin's Lymphoma (NHL) in Human Immunodeficiency Virus (HIV) infection is an Acquired Immunodeficiency Syndrome (AIDS) defining malignancy which can present with generalized lymphadenopathy. HIV itself has a 60-to-200-fold increase in risk for NHL, and most of the NHL in HIV infection are aggressive B cell-type with wide histological variation. Primary Central Nervous System lymphoma (PCNSL) and Burkitt lymphoma (BL) are the two most common types of Diffuse Large B-cell Lymphomas (DLBCL) associated with HIV infection. Mantle Cell Lymphoma (MCL) is a rare and aggressive form of NHL arising from the "Mantle Zone" of the lymph nodes. MCL is not a common type of NHL described in HIV infection. We report a case of MCL in 34-year-old HIV-infected women presented with generalized lymphadenopathy and hepatosplenomegaly in Sri Lanka. Failure to adhere to antiretroviral therapy leading to uncontrolled HIV viral load and low CD4 count as risk factors for developing rare MCL is discussed.
- 30 April 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (1) , 23-28
Open AccessMantle cell lymphoma in HIV infection: First reported case in Sri Lanka
Non Hodgkin's Lymphoma (NHL) in Human Immunodeficiency Virus (HIV) infection is an Acquired Immunodeficiency Syndrome (AIDS) defining malignancy which can present with generalized lymphadenopathy. HIV itself has a 60-to-200-fold increase in risk for NHL, and most of the NHL in HIV infection are aggressive B cell-type with wide histological variation. Primary Central Nervous System lymphoma (PCNSL) and Burkitt lymphoma (BL) are the two most common types of Diffuse Large B-cell Lymphomas (DLBCL) associated with HIV infection. Mantle Cell Lymphoma (MCL) is a rare and aggressive form of NHL arising from the "Mantle Zone" of the lymph nodes. MCL is not a common type of NHL described in HIV infection. We report a case of MCL in 34-year-old HIV-infected women presented with generalized lymphadenopathy and hepatosplenomegaly in Sri Lanka. Failure to adhere to antiretroviral therapy leading to uncontrolled HIV viral load and low CD4 count as risk factors for developing rare MCL is discussed.
- Open Access
- 31 December 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (3) , 69-72
Cerebellar stroke in a young female associated with elevated homocysteine levels and heterozygous MTHFR C677T gene: A case report.
Homocysteine is an amino acid, which is an intermediate in the metabolism of methionine and cysteine. Elevated homocysteine levels are recognized as a cause for both arterial and venous thrombotic phenomena. Methylenetetrahydrofolatereductase -encoded by MTHFR gene- is the rate-limiting enzyme of the remethylation of homocysteine to methionine. Homozygous MTHFR T677T gene mutation can independently cause raised homocysteine levels and increase the risk of thrombosis whereas heterozygous MTHFR C677T gene mutation usually does with an acquired cause such as folate or vitamin B12 deficiency, and is with lesser risk for thrombosis. We report a case of a previously healthy 23-year-old female, who was excluded from other inherited and acquired thrombophilic conditions, but was found to be having heterozygous MTHFR C677T gene mutation and elevated level of homocysteine presented late with right cerebellar stroke. Therefore, when young patients present with thrombotic phenomena, homocysteine levels should be assessed in the absence of other common thrombophilic conditions.
- 31 December 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (3) , 69-72
Open AccessCerebellar stroke in a young female associated with elevated homocysteine levels and heterozygous MTHFR C677T gene: A case report.
Homocysteine is an amino acid, which is an intermediate in the metabolism of methionine and cysteine. Elevated homocysteine levels are recognized as a cause for both arterial and venous thrombotic phenomena. Methylenetetrahydrofolatereductase -encoded by MTHFR gene- is the rate-limiting enzyme of the remethylation of homocysteine to methionine. Homozygous MTHFR T677T gene mutation can independently cause raised homocysteine levels and increase the risk of thrombosis whereas heterozygous MTHFR C677T gene mutation usually does with an acquired cause such as folate or vitamin B12 deficiency, and is with lesser risk for thrombosis. We report a case of a previously healthy 23-year-old female, who was excluded from other inherited and acquired thrombophilic conditions, but was found to be having heterozygous MTHFR C677T gene mutation and elevated level of homocysteine presented late with right cerebellar stroke. Therefore, when young patients present with thrombotic phenomena, homocysteine levels should be assessed in the absence of other common thrombophilic conditions.
- Open Access
- 21 July 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (2) , 58
Multiple myeloma
- 21 July 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (2) , 58
Open AccessMultiple myeloma
- Open Access
- 24 December 2022
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 16 (3)
A young female with bronze diabetes and cardiac failure due to juvenile haemochromatosis: A case report
- 24 December 2022
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 16 (3)
Open AccessA young female with bronze diabetes and cardiac failure due to juvenile haemochromatosis: A case report
- Open Access
- 15 July 2022
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 16 (2) , 41
Respiratory muscle paralysis in a patient with hypokalemia associated with Southeast Asian ovalocytosis: A case report
- 15 July 2022
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 16 (2) , 41
Open AccessRespiratory muscle paralysis in a patient with hypokalemia associated with Southeast Asian ovalocytosis: A case report